Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
InventisBio
280
InventisBio
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
Suggest edits
Founded
2013
Raised
$236M
Follow us
Also headquartered in Shanghai
Solar Power Inc.
ByteDance
Metaverse
Nio
NIO
Ctrip
Pinduoduo
ByteDance
SMIC
Gobi Partners
Companies in the same industry
IDP Pharma
Galena Biopharma
AFFiRiS AG
Sartorius
Frontida BioPharm, Inc.
Cyclica Inc.
Methylation Sciences
Premier Research
Scythian Biosciences
Neumentum, Inc.
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$147,000,000
Venture capital (Series D) - 2020
QiMing Venture Partners
Ltd
OrbiMed
+8
$70,000,000
Venture capital (Series C) - 2019
OrbiMed
Lilly Asia Ventures
Advantech Capital
+1
Team Size
1–10
Employees
I work here
Location
Shanghai
,
China
Headquarters
Explore Shanghai
$147,000,000
Venture capital (Series D)
FinSMEs
InventisBio Raises $147M in Series D Financing
FinSMEs
InventisBio Closes $70 Million USD Series C Financing
$19,000,000
Venture capital (Series B)
ChinaMoneyNetwork
,
PE HUB
,
AVCJ
OrbiMed Asia Leads $19M Series B Round In Biotech Start-Up InventisBio
Funding
Asia
Health
